Preventing frailty and aging-related diseases through lifestyle changes
A Multicenter, Feasibility Randomized Controlled Study to Evaluate the Applicability and Safety of the Software 'SUPERAGING' for Cognitive Therapy and Musculoskeletal Analysis in Frail or Prefrail Patients
This study is testing a mobile app that helps older adults improve their health and manage frailty through exercise, brain training, nutrition tips, and disease management over 16 weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 60 Years to 90 Years |
| Sex | All |
| Sponsor | Inha University Hospital Academic / other |
| Locations | 3 sites (Incheon and 2 other locations) |
| Trial ID | NCT06891573 on ClinicalTrials.gov |
What this trial studies
This feasibility randomized controlled trial aims to evaluate the effectiveness of a mobile app that delivers customized interventions to improve symptoms of frailty in older adults. Participants aged 60-90 will engage in a 16-week program that includes physical exercise, cognitive training, nutritional guidance, and disease management, all facilitated through the app. The study will primarily assess adherence, retention rates, and recruitment rates to determine the applicability of this intervention for frail individuals.
Who should consider this trial
Good fit: Ideal candidates are community-dwelling individuals aged 60-90 with a modified Fried frailty phenotype score of 1 or higher.
Not a fit: Patients with major psychiatric illnesses, dementia, or other serious medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and functional independence of older adults suffering from frailty.
How similar studies have performed: Previous studies have shown promise in using lifestyle interventions to address frailty, but this specific approach utilizing a mobile app is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 60-90 years of age * Residing in the community * Total score of Modified Fried frailty phenotype score ≥ 1 point * Korean Mini-Mental State Examination-2 z-score ≥ -1.5 * Can read and write * Being able to use the a mobile app through education or having someone help a participant use the mobile app * Having a reliable informant who could provide investigators with the requested information. * written informed consent Exclusion Criteria: * Major psychiatric illness such as major depressive disorders * Dementia * Other neurodegenerative disease (e.g., Parkinson's disease) * Malignancy within five years * Cardiac stent or revascularization within one year * Serious or unstable symptomatic cardiovascular disease * Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease * Severe loss of vision, hearing, or communicative disability * Significant laboratory abnormality that may result in cognitive impairment * Any conditions preventing cooperation as judged by the study physician * Unable to participate in exercise program safely * Coincident participation in any other intervention trial
Where this trial is running
Incheon and 2 other locations
- Inha University Hospital — Incheon, South Korea (Recruiting)
- Ewha Womans University Seoul hospital — Seoul, South Korea (Not_yet_recruiting)
- Ajou University Hospital — Suwon, South Korea (Not_yet_recruiting)
Study contacts
- Principal investigator: Seong Hye Choi, MD, PhD — Inha University Hospital
- Study coordinator: Seong Hye Choi, MD, PhD
- Email: sseonghye@inha.ac.kr
- Phone: 82 10-3120-2947
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.